According to the recent research report titled ‘GLOBAL Protein Expression Market 2019-2028’, available with Market Study Report, global protein expression market size is projected to expand at 11.30% CAGR during 2019-2028.
 

Increasing research & development of proteomics and genomics, rising healthcare expenditure, and growing pervasiveness of chronic diseases are the key factors stimulating global protein expression market growth. In addition, expanding pharmaceutical sector in emerging regions is also adding to the overall market outlook.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3552714/
 

Coming to the restraints, strict regulatory approval and hefty cost of protein expression systems are likely to have a negative impact on this business sphere over the coming years. Moreover, implications of COVID-19 and lack of efficient systems for post-translation modifications are anticipated to hamper worldwide protein expression industry remuneration.
 

With respect to product type, the market is divided into services, instruments, component cells, expression vectors, and reagents. Based on application spectrum, global protein expression industry is split into research, industrial, and therapeutic segments.
 

Elaborating on end user scope, the market is classified into contract research organizations, academic research institutes, pharmaceutical & biotechnology companies, and others.
 

Considering the regional terrain, Asia-Pacific protein expression industry share is projected to gain momentum over the analysis period, creditable to rising cognizance regarding advantages of protein expression and their growing usage in therapeutics.
 

The region is expected to provide enormous growth opportunities for the studied market due to improving health standards and increasing applications of this method. Rising disposable income is also adding impetus to the overall market expansion in Asia-Pacific.
 

Key players impacting global protein expression market dynamics are Peak Proteins Ltd., ProMab Technologies Inc., biotechrabbit GmbH, New England Biolabs (NEB), Lonza Group AG, Thermo Fisher Scientific Inc., Takara Holdings Inc., Qiagen, Promega Corporation, Merck KGaA, LifeSensors Inc., GenScript, Bio-Rad Laboratories Inc., Becton, Dickinson and Company (BD), and Agilent Technologies Inc.